Predicting worse survival for newly diagnosed T cell lymphoma based on the decreased baseline CD16−/CD16 + monocyte ratio

Abstract T cell non-Hodgkin lymphoma (T-NHL) is highly invasive and heterogeneous without accurate prognosis prediction. We proposed peripheral CD16−/CD16 + monocytes the additional indicators for T-NHL prognosis. We prospectively recruited 31 T-NHL patients without previous treatment. The CD16−/CD1...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Wei Zhang, Jing Ruan, Daobin Zhou, Xiao Han, Yan Zhang, Wei Wang, Mingqi Ouyang
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2020
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/bfbd3300020d4a10adffab995f9d4604
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:bfbd3300020d4a10adffab995f9d4604
record_format	dspace
spelling	oai:doaj.org-article:bfbd3300020d4a10adffab995f9d46042021-12-02T14:49:43ZPredicting worse survival for newly diagnosed T cell lymphoma based on the decreased baseline CD16−/CD16 + monocyte ratio10.1038/s41598-020-64579-z2045-2322https://doaj.org/article/bfbd3300020d4a10adffab995f9d46042020-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-64579-zhttps://doaj.org/toc/2045-2322Abstract T cell non-Hodgkin lymphoma (T-NHL) is highly invasive and heterogeneous without accurate prognosis prediction. We proposed peripheral CD16−/CD16 + monocytes the additional indicators for T-NHL prognosis. We prospectively recruited 31 T-NHL patients without previous treatment. The CD16−/CD16 + monocyte ratio before chemotherapy was calculated and regular follow up was performed to calculate prognostic prediction value. Tumor associated macrophages (TAM) in tumor tissue were counted and transcriptome sequencing of CD16− and CD16 + monocytes was applied to explore potential mechanisms. We found that T-NHL patients had higher ratio of total monocytes especially the CD16 + monocytes along with a decreased ratio of CD16−/CD16 + monocytes, compared to the health control. The 1-year overall survival rate was 0.492 and 0.755 for CD16− monocyte/CD16 + monocyte ratio of <11 and ≥11(p < 0.05), respectively. The peripheral CD16−/CD16 + monocyte ratio was significantly relevant with the pathological CD68/CD206 macrophage ratio. The differently expressed genes in CD16− and CD16 + monocytes from T-NHL patients were mainly involved in signaling molecules related to tumor microenvironment. Pro-tumor genes were identified in monocyte subsets especially in CD16 + monocytes. In conclusion, the ratio of peripheral CD16−/CD16 + monocyte helps to stratify the prognosis of T-NHL. The relatively increased CD16 + monocytes may contribute to the pro-tumor microenvironment of T-NHL.Wei ZhangJing RuanDaobin ZhouXiao HanYan ZhangWei WangMingqi OuyangNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-9 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Wei Zhang Jing Ruan Daobin Zhou Xiao Han Yan Zhang Wei Wang Mingqi Ouyang Predicting worse survival for newly diagnosed T cell lymphoma based on the decreased baseline CD16−/CD16 + monocyte ratio
description	Abstract T cell non-Hodgkin lymphoma (T-NHL) is highly invasive and heterogeneous without accurate prognosis prediction. We proposed peripheral CD16−/CD16 + monocytes the additional indicators for T-NHL prognosis. We prospectively recruited 31 T-NHL patients without previous treatment. The CD16−/CD16 + monocyte ratio before chemotherapy was calculated and regular follow up was performed to calculate prognostic prediction value. Tumor associated macrophages (TAM) in tumor tissue were counted and transcriptome sequencing of CD16− and CD16 + monocytes was applied to explore potential mechanisms. We found that T-NHL patients had higher ratio of total monocytes especially the CD16 + monocytes along with a decreased ratio of CD16−/CD16 + monocytes, compared to the health control. The 1-year overall survival rate was 0.492 and 0.755 for CD16− monocyte/CD16 + monocyte ratio of <11 and ≥11(p < 0.05), respectively. The peripheral CD16−/CD16 + monocyte ratio was significantly relevant with the pathological CD68/CD206 macrophage ratio. The differently expressed genes in CD16− and CD16 + monocytes from T-NHL patients were mainly involved in signaling molecules related to tumor microenvironment. Pro-tumor genes were identified in monocyte subsets especially in CD16 + monocytes. In conclusion, the ratio of peripheral CD16−/CD16 + monocyte helps to stratify the prognosis of T-NHL. The relatively increased CD16 + monocytes may contribute to the pro-tumor microenvironment of T-NHL.
format	article
author	Wei Zhang Jing Ruan Daobin Zhou Xiao Han Yan Zhang Wei Wang Mingqi Ouyang
author_facet	Wei Zhang Jing Ruan Daobin Zhou Xiao Han Yan Zhang Wei Wang Mingqi Ouyang
author_sort	Wei Zhang
title	Predicting worse survival for newly diagnosed T cell lymphoma based on the decreased baseline CD16−/CD16 + monocyte ratio
title_short	Predicting worse survival for newly diagnosed T cell lymphoma based on the decreased baseline CD16−/CD16 + monocyte ratio
title_full	Predicting worse survival for newly diagnosed T cell lymphoma based on the decreased baseline CD16−/CD16 + monocyte ratio
title_fullStr	Predicting worse survival for newly diagnosed T cell lymphoma based on the decreased baseline CD16−/CD16 + monocyte ratio
title_full_unstemmed	Predicting worse survival for newly diagnosed T cell lymphoma based on the decreased baseline CD16−/CD16 + monocyte ratio
title_sort	predicting worse survival for newly diagnosed t cell lymphoma based on the decreased baseline cd16−/cd16 + monocyte ratio
publisher	Nature Portfolio
publishDate	2020
url	https://doaj.org/article/bfbd3300020d4a10adffab995f9d4604
work_keys_str_mv	AT weizhang predictingworsesurvivalfornewlydiagnosedtcelllymphomabasedonthedecreasedbaselinecd16cd16monocyteratio AT jingruan predictingworsesurvivalfornewlydiagnosedtcelllymphomabasedonthedecreasedbaselinecd16cd16monocyteratio AT daobinzhou predictingworsesurvivalfornewlydiagnosedtcelllymphomabasedonthedecreasedbaselinecd16cd16monocyteratio AT xiaohan predictingworsesurvivalfornewlydiagnosedtcelllymphomabasedonthedecreasedbaselinecd16cd16monocyteratio AT yanzhang predictingworsesurvivalfornewlydiagnosedtcelllymphomabasedonthedecreasedbaselinecd16cd16monocyteratio AT weiwang predictingworsesurvivalfornewlydiagnosedtcelllymphomabasedonthedecreasedbaselinecd16cd16monocyteratio AT mingqiouyang predictingworsesurvivalfornewlydiagnosedtcelllymphomabasedonthedecreasedbaselinecd16cd16monocyteratio
_version_	1718389472039534592

Predicting worse survival for newly diagnosed T cell lymphoma based on the decreased baseline CD16−/CD16 + monocyte ratio

Ejemplares similares